NYSE · KNF

Knife River Corporation

$78.54 +$0.48 (+0.61%) 1D Market open
Charting by TradingView

Key Metrics

$4.43B
Market cap
30.22×
P/E · TTM
$3.20B
Revenue · TTM
$146.61M
Net income
EPS · TTM $2.59
Dividend yield —
Free cash flow −$5.20M
Beta · 1Y 1.32
EBITDA · TTM $406.08M
Gross margin 18.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 8
    The stock moved +10.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 8
  • Feb 17
    The stock moved +16.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.43B
Enterprise value$5.85B
Shares outstanding56.8M
52-wk range$58.72 – $96.28
Avg volume · 20D543.3K
Net cash −$1.42B
Book value / share$27.54
IndustryMining & Quarrying Of Nonmetallic Minerals (No Fuels)
ExchangeNYSE
About Knife River Corporation
IPO dateMay 25, 2023
Employees5298

Knife River Corp is a people-first construction materials and contracting services company. It provides construction materials and contracting services to build safe roads, bridges, airport runways, and other critical infrastructure needs that connect people.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E30.22
P/S1.38
P/FCF—
EV/EBITDA14.41
EV/Sales1.83
Graham №$40.05

Profitability

Gross 18.2%
Operating 6.2%
Net 4.6%
FCF -0.2%
ROE / ROIC 9.7% · 4.9%

Financial Health

Current ratio2.67
Quick ratio1.31
Debt / equity0.92
Debt / EBITDA 3.53
Net cash −$1.42B
Working capital$590.02M

Cash Flow · TTM

Operating CF $345.20M
Capex −$350.40M
Free cash flow −$5.20M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

2.7
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$40.05 vs $78.54
Trades 2.0× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings